Background and aims: Gastrointestinal (GI) proteases are best known for their function in protein digestion. However, GI luminal serine protease activity is also associated with inflammation, pain and visceral hypersensitivity via activation of protease-activated receptor-2 (PAR-2). An infant milk formula comprising product fermented by Streptococcus thermophilus 065 and Bifidobacterium breve C50 has previously been reported to improve gut comfort in infants with digestive problems. Here, the effect of this fermented formula (Lactofidus) on proteolytic activity was investigated at the terminal ileum.
